A total of 37 children with refractory widespread atopic eczema were treated with an antigen avoidance regimen comprising hospitalisation, exclusive feeding with an elemental formula for a median duration of 30 days, and measures to reduce exposure to pet and dust mite antigens at home. After the initial period of food exclusion, food challenges were performed at intervals of seven days, and the patients followed up for at least 12 months.
A total of 37 children with refractory widespread atopic eczema were treated with an antigen avoidance regimen comprising hospitalisation, exclusive feeding with an elemental formula for a median duration of 30 days, and measures to reduce exposure to pet and dust mite antigens at home. After the initial period of food exclusion, food challenges were performed at intervals of seven days, and the patients followed up for at least 12 months. Ten of the children (27%) either failed to respond to the regimen or relapsed within 12 months. Improvement in the eczema was seen in 27/37 (73%) patients, by discharge from hospital their disease severity score had fallen to a median of 27% of the pretreatment figure, and only 3/27 required topical corticosteroids. There were no clinical or laboratory findings which could be used to predict the outcome. Drawbacks to the regimen were prolonged hospitalisation (median 70 days), a fall in body weight and serum albumin concentration, and a risk of anaphylactic shock (4/37 cases). A strict antigen avoidance regimen may be associated with improvement of atopic eczema where conventional treatments have failed.
disease after stopping treatment, and risks of renal toxicity and lymphoma production are major drawbacks. Topical cyclosporin appears less effective.6 Anecdotal reports of treatment with cytotoxic agents (cyclophosphamide, azathioprine, mustine, thioguanine, and aminopterin) describe temporary benefit, but bone marrow toxicity, lymphoma production, and sterility are deterrents to the use of these agents. Interferon gamma has been tried, with some degree of benefit,7 but the temporary nature of the improvement and the need for injections are drawbacks.
Where a case of atopic eczema is refractory to conventional treatment, the question arises as to whether part or all of the disease can be attributed to allergic reactions to items such as food, pets, or dust mites. Accordingly, and only as a last resort, we have in exceptionally difficult cases tried an extreme antigen avoidance regimen, which comprises a prolonged so called elemental diet while in hospital, accompanied by measures to reduce exposure to pet and dust mite antigens upon return home. We report on 37 children with severe atopic eczema who were treated in this way.
A small proportion of children with atopic eczema remain severely handicapped with severe and widespread eczematous skin lesions. This may happen despite the most intensive application of conventional treatment,' such as emollients, topical steroids, antibiotics for infection, bedtime sedating antihistamines, and avoidance of allergic (for example, pets or foods2) or non-allergic (for example, heat or woollen clothing) triggers that have been identified from the history. In such extreme cases, the traditional additional therapeutic options are unappealing. They comprise the application of potent topical steroids to large areas of skin, with the risk of skin atrophy and growth stunting, the use of systemic steroids, with the risk of growth stunting, cataract All normal food and drink (including water) were excluded, and the child was fed exclusively on unlimited quantities of unflavoured Vivonex. To minimise the possibility of osmotic diarrhoea, patients were started at a low concentration (6-7 g/100 ml, 140 mOsm/kg), gradually increasing to isotonicity (13 g/100 ml, 280 mOsm/kg) on the third day. If this did not provoke loose stools, the concentration was increased further to a maximum of 26 7 g/100 ml (560 mOsm/kg). The (73) 22 (59) 20 (54) 17 (55) 4 (11) 4 (11) 4 (11) 6 (16) 8 (26) 3 (8) 3 (8) 7 (19) 7 (19) 3 (10) 3 (8) 3 (8) 4 (11) 4 (11) 3 (10) 16 (64) 11 (69) 9 (75) 8 (89) 7 (28) 4 (25) 3 (25) 1 (11) 1 (4) 1 (6) The median fall in serum albumin concentration in the six late failure patients (13.5 g/l) was also greater than in the patients who responded to treatment, but the difference was not significant (p>O 1). In 27/37 (73%) patients there was sustained improvement in the eczema. With one exception, where clear improvement was seen within seven days of commencing the elemental diet, the first signs of improvement were not seen for at least one, and more commonly two weeks. It was usually only after four weeks of exclusive feeding on Vivonex, however, that there was substantial improvement in the appearance of the skin lesions. The greatest improvement occurred during the period on Vivonex alone, when the median disease severity score fell to 27% of the pretreatment score (range 3 to 67%). Before treatment, 14/27 (52%) had been using category IV topical corticosteroids, 12/27 (44%) had been using category III or II topical corticosteroids, and one patient was receiving oral prednisolone. At 
Discussion
The aim of this regimen was to achieve a period in hospital of near complete antigen avoidance, and to maximise the avoidance of relevant anti-gens during follow up. The chief obstacles were the unpleasant taste of the elemental formula and difficulty in avoidance of inhalant antigens. In fact most children drank the formula after a short period (less than 24 hours) of refusal, and were helped by understanding the aim of the diet. Some children preferred the formula warm, others cold, and two would only take it in the form of ice lollies or crushed ice. Nevertheless, constant scrutiny and encouragement by the nurses and dietitians was required to ensure an adequate intake, and also to prevent other residents on the ward from leaving food or drink accessible to the patient. In one case taps had to be removed in the patient's cubicle to prevent the child drinking water instead of formula, and two children completely refused to drink the formula and in these the regimen was abandoned. Measures to reduce exposure to house dust mites' and pets at home were an integral part of the regimen. The former often entailed considerable expense (for example, replacement of bedroom carpet by cushion flooring; replacement of bed base by non-divan type of bed). The need to remove pets was usually most unpopular, and was sometimes seen by parents to be a greater problem than a period of two to three months of hospitalisation. Most families were helped by a pretreatment visit to another family who had been treated with the regimen, and who were often able to describe exacerbations of eczema after pet exposure and which had only been noted once the eczema had improved while on the regimen. Avoidance of inhalant antigens such as pollens or mould spores was not attempted.
Elemental diets are potentially hazardous. Weight loss despite a theoretically adequate (that is, above the recommended daily amount'4) intake in 30/34 (89%) and a reduction in the serum albumin in 25/27 (93%) were the most commonly encountered problems. These probably reflect the increased metabolic demands of a child with widespread and long standing skin inflammation. Loose stools occurred in 7/37 (19%), were attributed to the hypertonicity of Vivonex, and responded to a reduction in concentration. The occurrence of four cases of anaphylactic shock emphasises the potential hazards of food challenges in children with food allergy. This aspect is discussed elsewhere.'1'7 Thirty patients received hypertonic concentrations of Vivonex. It has been shown in rats that hypertonic feeds may cause increased jejunal permeability to macromolecules'8 and structural damage to jejunal microvilli. '9 It is theoretically possible that the former could contribute to a severe hypersensitivity reaction during a food challenge. Such speculation does not have to be invoked to explain our cases of anaphylactic shock, however, which is a well recognised hazard for some children with food allergy. '6 As far as assessing the benefit of this antigen avoidance regimen, there are three main drawbacks to our methodology. The lack of a control group means that it is not possible to assess how much improvement was due to a placebo effect. It would be desirable, but impractical, to have a control group of patients admitted to hospital for several months but given instead a liquid preparation of normal food, and it would be impossible to disguise the poor flavour of Vivonex. An alternative would be to conduct a randomised study, with half the patients being randomised to a non-treatment arm, and this would be informative for there are no data on the natural history of exceptionally severe atopic eczema. This is important, for in a recent study of a less demanding dietary regimen in a group of less severely affected children with atopic eczema, the outcome at 12 months was the same regardless of response to diet.20 It is a common but undocumented observation that atopic eczema sometimes improves swiftly after admission to hospital, whether or not topical corticosteroids have been continued. The usual suggested explanations for this are noncompliance with topical treatment at home, or removal from potential sources of antigens in the home such as pet animals or house dust mites.2' The observation that in the present study recovery was rather slow, and continued after discharge, suggests that none of these explanations account for the improvement that occurred in hospital in our patients.
The second methodological drawback is that our patients do not represent a homogeneous category, and were selected solely on the grounds of severity and lack of response to conventional treatment. It is clear that only some of this group are potential responders to antigen avoidance regimens, and it is most unsatisfactory that we were unable to identify any biochemical, immunological, or historical marker that would predict the outcome of the regimen. The difficulty in identifying those who are likely to respond to dietary elimination has been noted before. 22 The third problem that bedevils all studies of atopic eczema is the lack of an objective method for assessing disease severity. We It is generally agreed that double blind, placebo controlled food challenge with tiny quantities of encapsulated freeze dried foods is the best method for confirming adverse reactions to foods. 17 Nevertheless, there are a number of circumstances where such challenges may give a misleading and incorrect result.15 Our challenges were not performed blind, but double blind challenges with normal food portions would be difficult to perform in a child receiving Vivonex alone, where a new food could not be disguised in a 'carrier' food. The alternative option of feeding via a nasogastric tube would be unacceptable to most children, and would bypass the oral mucosa, possibly leading to a false negative reaction.25 Finally, double blind challenges for three foods, using a seven day period for active challenge, placebo and washout, and repeated three times to reduce the probability of error,26 would have extended the period of hospital admission by more than two months. Although we used open challenges, the circumstances were such as to favour a negative challenge, and avoid false positive results. Foods least likely to produce an adverse reaction were deliberately chosen for challenges, so that children could be discharged from hospital and then established on a reasonable diet as quickly as possible. The patients were strongly motivated to tolerate new foods, having been in hospital for a month or more on a highly unpalatable liquid diet. Such circumstances do not exclude bias and overdiagnosis of food allergy, but the lack of double blind methodology cannot explain away the 40 adverse reactions witnessed by nursing and medical staff in hospital and followed by improvement after food withdrawal. The data on outpatient challenges are less secure because they were not supported by constant nursing and medical observation. Despite several limitations, the present study has demonstrated that a highly intrusive (minimum hospitalisation two months) and potentially hazardous antigen avoidance regimen was associated with great benefit in some children previously handicapped by refractory, widespread atopic eczema. In the present series, 27 of 37 (37%) such children experienced sustained improvement, although in none did the eczema disappear completely. In four (11%) patients the treatment failed outright, and in six (16%) an initial improvement was soon followed by relapse and return to the pretreatment state. It is not possible to estimate how much benefit was due to food or other antigen avoidance. Adverse reactions to pets, house dust, and grass were noted in 19/37 (51%) patients after discharge from hospital. The slow rate of improvement seen in this study, however, contrasts with the undocumented but often observed rapid improvement seen when some patients go on holiday or are admitted to hospital. This suggests that avoidance of environmental antigens was not the major factor causing improvement in our patients.
Recent paediatric2 and dermatological37 estimates are that no more than 10% of children with atopic eczema severe enough to warrant referral to hospital are likely to derive lasting benefit from the use of an elimination diet. In the sole previous study of the use of an elemental diet in the treatment of atopic eczema in childhood, seven children received an elemental feed for only two weeks.38 This was followed by six other foods for four weeks. The eczema score improved considerably in six, but in four of these there was little deterioration after returning to a normal diet. In a recent study of 25 children with atopic eczema, either a whey hydrolysate milk formula or Vivonex was given for one to two weeks followed by challenges with foods and food additives. It was noted that in 71% of patients there was appreciable improvement of the eczema, but only scanty follow up data were available.39
This study has two important implications. The first is that there may be a case for trying an elemental diet in a child with severely handicapping atopic eczema which has not responded to simpler diets and conventional topical treatment. The need for a further randomised study is clear. The potential hazards of elemental diets, and the need for very close monitoring, indicate that this is an approach that can only be safely undertaken in hospital, with full paediatric and dietetic support. The second implication is that delayed and probably non-IgE mediated eczematous reactions to foods occur in some children with atopic eczema, and merit more detailed and double blind evaluation.
